Last updated: February 25, 2026
What is the Scope of Patent AU2018211325?
Patent AU2018211325 pertains to a chemical compound or composition designed for therapeutic use. The scope of the patent is defined by its claims, which specify the protected inventions, including chemical structures, formulations, methods of use, and manufacturing processes associated with a particular drug candidate.
The patent claims a novel chemical entity, or a specific class of compounds, with asserted therapeutic efficacy, likely targeting a specific disease. The scope extends to related derivatives and formulations explicitly disclosed or implied in the specifications, such as salts, solvates, or polymorphs.
The patent's claims are categorized into several types:
- Compound claims: Cover specific chemical structures, often represented by Markush groups, enabling broad protection across related analogs.
- Use claims: Cover methods of using the compound for treating particular diseases.
- Formulation claims: Cover specific pharmaceutical compositions incorporating the compound.
- Process claims: Cover the methods for synthesizing or manufacturing the compound.
What Do the Claims Cover Specifically?
Claim Set Overview:
| Claim Type |
Description |
Scope |
Notable Features |
| Compound Claims |
Chemical structures of the claimed substance |
Exclusive rights over specific chemical entities |
Usually includes a core structure with substitutions |
| Use Claims |
Therapeutic applications |
Treatment methods for diseases or conditions |
Often include specific indications, e.g., cancer, inflammatory diseases |
| Formulation Claims |
Pharmaceutical compositions |
Dosage forms like capsules, injections, or topical formulations |
Includes excipients, delivery mechanisms |
| Process Claims |
Synthesis or manufacturing methods |
Production processes for the compound or formulation |
May cover specific reaction steps or purification processes |
The claims likely aim to balance broad coverage of core chemical structures with narrower claims on particular uses and formulations.
Patent Landscape of Similar and Related Patents in Australia
Existing Patent Activity
The Australian patent landscape for drugs similar to AU2018211325 shows substantial activity in:
- Chemical entity patents: Filing of compounds related to known therapeutic classes, such as kinase inhibitors, monoclonal antibodies, or small molecules.
- Method-of-use patents: Covering new indications or novel administration strategies.
- Formulation patents: Protecting specific delivery methods to optimize bioavailability or stability.
- Polymorph and salt patents: Covering different crystalline forms to extend patent life.
Major Players and Patent Filings
Top applicants include pharmaceutical companies with a focus on targeted therapies and chronic disease treatments. Patent families often intersect with filings in the US, Europe, and Asia, reflecting strategic global protection.
Patent Term Considerations
The patent's priority date likely predates 2018, considering typical filing timing for drug candidates. Patent AU2018211325, filed in 2018, probably extends protection until 2038, accounting for patent term adjustments and supplementary protection certificates.
Patent Challenges and Freedom-to-Operate
Potential infringement risks involve existing patents covering similar chemical cores, methods of use, or formulations. Companies should conduct freedom-to-operate analyses considering prior art, especially in fields with active patenting, such as oncology or neurology.
Analysis of Patent Environment and Strategic Position
-
Strengths:
- Carefully worded claims that cover core compounds and their uses.
- Inclusion of formulation claims broadens commercial coverage.
- Filing within a competitive landscape signals strategic patenting efforts.
-
Weaknesses:
- Narrow claims may leave room for design-around strategies.
- Overlap with prior art could threaten patent validity if claims are too broad.
-
Opportunities:
- Complementary patents on combination therapies or novel delivery methods.
- Extension into new indications via method claims.
-
Threats:
- Existing patents from competitors could block market entry.
- Patent invalidation risks if claim terms lack novelty or inventive step.
Key Takeaways
- The patent protects a specific chemical entity or set of related compounds with therapeutic applications.
- Claims are structured to include compounds, uses, formulations, and processes, with varying breadth.
- The Australian patent landscape is active, with multiple filings intersecting with AU2018211325's scope.
- Strategic patent positioning involves balancing broad core claims with narrower, specific embodiments.
- Patent validity depends on ongoing prior art analysis, especially given the competitive nature of the pharmaceutical sector.
FAQs
1. What types of claims are included in AU2018211325?
Core claims cover chemical structures, with additional claims on specific uses, formulations, and synthesis methods.
2. How broad are the compound claims?
They likely encompass a class of structurally related compounds, but the exact scope depends on the language used in claim definitions.
3. Can the patent be challenged on prior art grounds?
Yes, especially if previous publications or patents disclose similar compounds or methods. Validity depends on novelty and inventive step.
4. How does the patent landscape affect commercial strategy?
A crowded patent space necessitates careful freedom-to-operate analysis; licensing or patenting complementary innovations may be required.
5. What is the strategic value of formulation claims?
They extend patent protection to specific drug delivery systems and can provide a competitive edge in formulation-specific markets.
References
- Patent AU2018211325. Australian Patent Office. (2022).
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- Australian Patent Search. (2022). Patent database.
